Thoratec (NSDQ:THOR) yesterday reported higher-than-forecast earnings for the 4th quarter and 2014, crediting an extra selling week and better utilization rates for its implantable heart pumps.
Terumo
HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves
Analyst speculates Smith & Nephew split | Medtech Wall Street news for the week of Mar. 31, 2014
Terumo inks deal for Arterial Remodeling’s bioresorbable stent
Arterial Remodeling Technologies said it inked a deal with Terumo Corp. (TYO:4543) for its bioresorbable drug-eluting coronary stent that includes an exclusive buyout option.
Biomet puts itself back on public market | Medtech Wall Street news for the week of Mar. 10, 2014
Biomet announces IPO plans
March 7, 2014 by Brad Perriello
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
Siemens, GE named among worst-performing device makers of the year | MassDevice.com On Call
MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company’s in the industry’s top 40 haven’t been so fortunate.
Terumo inks distribution deals with CareFusion, Nonin Medical
Terumo Corp. (TYO:4543) sat on both sides of the table in inking a pair of distribution deals with CareFusion (NYSE:CFN) and Nonin Medical.
Terumo acquires Turkish blood bank distributor
Terumo BCT, a subsidiary of Terumo Corp. (TYO:4543), said it acquired its onetime blood products distributor GADA Turkey for an undisclosed amount.
GADA Turkey, a subsidiary of the GADA Group Holding, was a Terumo BCT distributor to blood banks and hospitals in Turkey since 2009.
Vascular Solutions settles Terumo patent infringement beef for $812k
U.S. Defense Dept. awards $196M in contracts to medical device companies
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.